Publicaciones (41) Publicaciones de Sergio Roa Gómez

2024

  1. Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol

    Frontiers in Nutrition, Vol. 11

2023

  1. Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

    Nature Medicine, Vol. 29, Núm. 3, pp. 632-645

  2. Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma

    Journal for immunotherapy of cancer, Vol. 11, Núm. 2

2022

  1. Correction to: Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells (Molecular Medicine, (2011), 17, 11-12, (1374-1382), 10.2119/molmed.2011.00360)

    Molecular Medicine

  2. Role of EXO1 nuclease activity in genome maintenance, the immune response and tumor suppression in Exo1D173Amice

    Nucleic Acids Research, Vol. 50, Núm. 14, pp. 8093-8106

2021

  1. The pd-1/pd-l1 checkpoint in normal germinal centers and diffuse large b-cell lymphomas

    Cancers, Vol. 13, Núm. 18

2020

  1. CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation

    Blood Advances, Vol. 4, Núm. 5, pp. 893-906

2019

  1. PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas

    Blood, Vol. 133, Núm. 22, pp. 2401-2412

  2. YRNAs overexpression and potential implications in allergy

    World Allergy Organization Journal, Vol. 12, Núm. 8

2018

  1. Detailed Exploration around 4-Aminoquinolines Chemical Space to Navigate the Lysine Methyltransferase G9a and DNA Methyltransferase Biological Spaces

    Journal of Medicinal Chemistry, Vol. 61, Núm. 15, pp. 6546-6573

  2. Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy

    Journal of Medicinal Chemistry, Vol. 61, Núm. 15, pp. 6518-6545

  3. Richter transformation driven by Epstein–Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia

    Journal of Pathology, Vol. 245, Núm. 1, pp. 61-73

2017

  1. Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies

    Nature Communications, Vol. 8

  2. MiR-28 regulates the germinal center reaction and blocks tumor growth in preclinical models of non-Hodgkin lymphoma

    Blood, Vol. 129, Núm. 17, pp. 2408-2419

2016

  1. Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics

    Nature Communications, Vol. 7

2014

  1. Genome-wide expression profiling of B lymphocytes reveals IL4R increase in allergic asthma

    Journal of Allergy and Clinical Immunology, Vol. 134, Núm. 4, pp. 972-975

2013

  1. Downregulation of FOXP1 is required during germinal center B-cell function

    Blood, Vol. 121, Núm. 21, pp. 4311-4320

  2. LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas

    British Journal of Haematology, Vol. 162, Núm. 5, pp. 621-630

  3. Mammalian Exo1 encodes both structural and catalytic functions that play distinct roles in essential biological processes

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 27

2012

  1. AIDing antibody diversity by error-prone mismatch repair

    Seminars in Immunology, Vol. 24, Núm. 4, pp. 293-300